---
title: "ENWEI PHARMACEUTICAL (301331.SZ) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/301331.SZ/norm.md"
symbol: "301331.SZ"
name: "ENWEI PHARMACEUTICAL"
parent: "https://longbridge.com/en/quote/301331.SZ.md"
datetime: "2026-03-13T20:32:49.705Z"
locales:
  - [en](https://longbridge.com/en/quote/301331.SZ/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/301331.SZ/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/301331.SZ/norm.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/301331.SZ/norm.md) | [繁體中文](https://longbridge.com/zh-HK/quote/301331.SZ/norm.md)


# ENWEI PHARMACEUTICAL (301331.SZ) — Financial Reports

## Income Statement (CNY)

| Indicator | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| EPS | -0.0176 | 0.2207 | 0.1631 | 0.1552 | 0.0406 |
| ROE | -0.65% | 8.16% | 6.11% | 5.95% | 1.61% |
| Revenue | 187.63M | 252.72M | 196.50M | 251.79M | 172.19M |
| Net income | -1.76M | 22.04M | 16.31M | 15.48M | 4.09M |
| Operating income | -8.20M | 28.86M | 13.46M | 18.04M | 4.84M |
| Gross margin | 45.29% | 50.47% | 48.13% | 48.63% | 49.82% |
| Net margin | -0.94% | 8.72% | 8.30% | 6.15% | 2.37% |
| Profit quality | -803.62% | 57.15% | 54.56% | 241.97% | -25.76% |

## Balance Sheet (CNY)

| Indicator | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| A&L | 1.50B | 1.52B | 1.50B | 1.50B | 1.42B |
| Leverage | 1.38 | 1.40 | 1.39 | 1.42 | 1.39 |
| BVPS | 10.72 | 10.71 | 10.79 | 10.46 | 10.23 |
| Turnover | 0.6087 | 0.5846 | - | 0.5715 | 0.5659 |
| Cash & STI | 524.94M | 535.07M | 523.32M | 515.00M | 495.66M |
| Inv & Rec | 114.49M | 112.89M | 116.62M | 115.55M | 107.49M |
| LT assets | 268.44M | 265.63M | 252.95M | 246.55M | 247.26M |
| Net debt | -332.85M | -342.85M | -325.57M | -317.12M | -293.70M |

## Cash Flow Statement (CNY)

| Indicator | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | 1.02M | 50.50M | 24.68M | 7.46M | -18.81M |
| Investing CF | -40.65M | -18.79M | -19.97M | -97.13M | -44.27M |
| Financing CF | -861340.00 | -24.75M | -828750.00 | 13.47M | -24.91M |
| Free CF | -60.49M | 49.30M | -16.61M | 67.49M | -98.31M |
| OCF coverage | 7.68% | 119.30% | 141.39% | 65.99% | -50.38% |
| Repaid & issued | - | - | - | 0.0000 | 0.0000 |
| CapEx | -12.42M | -16.75M | -17.45M | -4.14M | -16.42M |

## Distribution Plan

**Dividend Yield**: 1.90

### Dividend History

| Description | Record Date | Ex-Date | Payment Date |
|-------------|-------------|---------|--------------|
| Cash Dividend: 
0.34641CNY | 2026-01-07 | 2026-01-08 | 2026-01-08 |
| Cash Dividend: 
0.176823CNY | 2025-05-27 | 2025-05-28 | 2025-05-28 |
| Cash Dividend: 
0.778307CNY. 
Share conversation: 0.466 for 1 | 2024-05-22 | 2024-05-23 | 2024-05-23 |